Latest Stem cells Stories
-- Treatment being developed would use encapsulation to protect new insulin-producing cells derived from a stem cell precursor -- NEW YORK and SAN FRANCISCO, Feb. 13, 2013 /PRNewswire-USNewswire/ -- JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, and the California Institute for Regenerative Medicine (CIRM), California's stem cell agency, announced that they are providing additional funding for the development of a novel stem cell therapy by San...
STEMSOFT and the CBMTG are pleased to work together to create a national registry of patients who have undergone blood and marrow transplants in Canada. Vancouver, BC (PRWEB) February 12, 2013 The Canadian Blood and Marrow Transplant Group (“CBMTG”) is pleased to announce a partnership with STEMSOFT Software Inc. (“STEMSOFT”) that will result in a national registry of patients who have undergone blood and marrow transplants in Canada. “This registry will ensure that Canadian...
Clinical trial seeks to enroll people with disabling effects of ischemic stroke CHICAGO, Feb. 11, 2013 /PRNewswire-USNewswire/ -- Each year, nearly 800,000 Americans suffer a stroke which can result in permanent brain damage, long term disability or death. As a leading cause of adult disability, stroke has an annual burden of more than $62 billion on the United States economy. With the exception of rehabilitation therapy, very few treatments are available to improve the chronic...
Scientists at the University of Southampton have created a new method to generate bone cells which could lead to revolutionary bone repair therapies for people with bone fractures or those who need hip replacement surgery due to osteoporosis and osteoarthritis. The research, carried out by Dr Emmajayne Kingham at the University of Southampton in collaboration with the University of Glasgow and published in the journal Small, cultured human embryonic stem cells on to the surface of plastic...
NEW YORK, Feb. 11, 2013 /PRNewswire/-- Americord Registry announced that it would match any competitor's prices for cord blood banking and cord tissue banking. The guarantee is part of numerous efforts the company has underway to simplify cord blood banking for parents interested in keeping their child's most easily accessible stem cells after birth. The company is committed to providing the highest quality cord blood banking at the most affordable price and wants to make it easier...
ALBANY, New York, February 11, 2013 /PRNewswire/ -- New Market Research Report Added in MarketResearchReports.Biz Reports Database Cellular Therapy and Cord Blood 2013 Market Report [http://www.marketresearchreports.biz/analysis/160812 ] This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences [http://www.marketresearchreports.biz/publisher/38 ]. In this comprehensive market...
Stem cells taken from ALS patients may have the same capacity to develop into mature neuron-like cells as those collected from healthy donors, according to a new study released this month in STEM CELLS Translational Medicine. These findings could open doors to a possible new treatment option while also reducing the chance for rejection and other side effects often seen when someone other than the patient is the cell donor. Durham, NC (PRWEB) February 08, 2013 Stem cells taken from ALS...
SEOUL, South Korea, Feb. 8, 2013 /PRNewswire/ -- RNL BIO CO LTD (RNL) announced today the filing of an Investigational New Drug (IND) application with the Korean Food and Drug Administration (KFDA) to initiate clinical trials phase II and III assessing the company's RNL-Astrostem(TM) stem cell drug in patients with cerebral palsy. The purpose of this study is to assess conclusive efficacy of stem cells for the treatment of cerebral palsy in 45 subjects over 11 months. The study is to...
A single embryonic stem cell can develop into more than 200 specialized cell types that make up our body. This maturation process is called differentiation and is tightly regulated through strict control of gene activity. If the regulation is lost, specialized cells cannot develop correctly during development. In adulthood, the specialized cells may forget their identity and develop into cancer cells. Research from BRIC, University of Copenhagen, has identified a crucial role of the molecule...
Can stem cells provide an answer to the perplexing question of how to ensure long-term survival of transplanted kidneys? The results of a new Phase 1 clinical trial say maybe so. Details of the trial, conducted by researchers at Leiden University Medical Center, The Netherlands, are published in the current issue of STEM CELLS Translational Medicine. Durham, NC (PRWEB) February 07, 2013 Kidney transplants have long been the treatment of choice for many patients with end-stage renal...
